Any chance of an apology to the forum for this blatantly false claim from yesterday?…
‘We know that DEP has been effective in Pancreatic cancer Phase 3 trials so maybe DEP is assisting minimising adverse effects of chemotherapy’
~ @Starlink
A complete fabrication!
None of Starpharma’s DEP candidates have ever progressed to Phase 3. Ever.
In fact, all three Starpharma partnered trials with AstraZeneca were terminated during Phase One.
TGA interim decision re Astodrimer sodium nasal spray this week, page-2
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
0.004(4.17%) |
Mkt cap ! $41.73M | |||
| Open | High | Low | Value | Volume |
| 9.8¢ | 10.0¢ | 9.8¢ | $376.5K | 3.773M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6529 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 109523 | 2 |
View Market Depth
| Last trade - 16.10pm 09/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |